Adare Pharma Solutions Capacity Update May 2024: Small Molecule APl and HPAPI Development

In this presentation from the May 2024 OPCU event, Adare Vice President of Business Development Strategic Accounts Uli Foley discusses the importance of working with a CDMO that provides services at every step of the commercialization journey. An outsourcing partner with services from the earliest phases of development and formulation all the way to manufacturing and packaging pays tremendous dividends in terms of working with the same teams and the same points of contact throughout your product's full journey. This, in turn, helps you get your product to market with significant savings in costs and time.